MA-BRIGHTCOVE/SUNN-STRM
16.7.2024 15:01:59 CEST | Business Wire | Press release
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced it has added Sunn Stream – a streaming service offering family-friendly movies, music and educational content – to its roster of media customers. Sunn Stream will rely on Brightcove’s two-time Emmy-award-winning platform to distribute its content to audiences nationwide.
Sunn Stream, currently in soft launch, is a streaming service that provides subscribers with personalized, family-friendly content, including movies, music, episodic shows, and educational videos on various topics. Using Brightcove’s reliable and scalable video technology, Sunn Stream will provide its audience with a seamless, curated, user-friendly experience across all devices.
“The streaming industry has clearly become more competitive, with providers striving to capture the attention and loyalty of more discerning audiences,” said Brightcove CEO Marc DeBevoise. “With this evolution, Sunn Stream has realized that it is essential to combine its unique content proposition targeted at a clearly-defined audience with the highest-quality video streaming and an intuitive, personalized user experience. Using our market-leading technology platform, Sunn Stream will be at the forefront of providing their customers with reliable, customized entertainment options, and will have access to best-in-class analytics to track performance.”
The popularity of independent media companies has continued to surge. As more consumers enter the fold, these entities increasingly require partners that can scale with them and ensure that customer experience remains a top priority. Sunn Stream tapped Brightcove’s industry-leading video-cloud streaming platform for its unique advantages, including unparalleled video quality, global scalability, unmatched customer support, and robust analytics.
“We’ve completely updated our Sunn Stream streaming service and app to make them easier to use so more customers can enjoy our films and shows,” said Sunn Stream Founder and President Garrett Z. Sutton. “Our curators will now handpick unexpected recommendations that our customers will love. And we’re more focused on creating an experience for the whole family that brings people together with laughter, tears, and thought-provoking moments.”
Sunn Stream joins a roster of media companies that rely on Brightcove to power their streaming capabilities, including FrightPix, The Academy of Motion Picture Arts and Sciences, Acun Medya, AMC Networks, BBC Studios, Canela Media, J.COM, MotoAmerica, REELZ, SBT TV, and SKY Mexico.
For more information, visit Brightcove.com.
About Sunn Stream
Sunn Stream is more than a streaming platform — it’s an Uncharted Entertainment and Educational Journey that takes users to bold, new worlds of cinema and television with family-friendly online content (movies, music and more) and a new Sunn Stream Film Festival (Coming Soon in 2025). As a modern-day storytelling campfire, it unites people through laughter, tears, and thought-provoking moments. This user-friendly platform delivers new narratives and experiences that appeal to multiple generations. Each month, Sunn Stream’s content curators handpick a collection of unexpected tales that ignite wonder, invite conversations and bridge hearts and minds. In addition to films and exclusive documentaries, this online platform offers quality educational content to fill voids left by public institutions such as financial education. Sunn Stream Members/ Subscribers will have unlimited access to new content that can ignite discussions with friends and family. Founded in 2022, Sunn Stream Founder/President, Bestselling Author and Entrepreneur Garrett Z. Sutton is dedicated to entertaining, educating and expanding horizons for users with new content that enhances lives. And Sunn Stream’s unique platform can be experienced online via SunnStream.com, Sunn Stream Productions App (iOS for iPads and iPhones, Apps for Android) and through Roku, Chromecast, and/or Apple TV devices. And when the credits roll, the journey is just beginning: https://sunnstream.com.
About Brightcove Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716111027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom